• Aura Biosciences issued inducement equity awards on Sept. 1, 2026 to three newly hired executives.
• Options cover 677,000 shares at an exercise price of USD 7.43, matched to the Nasdaq close on the grant date.
• RSUs cover 343,009 shares.
• Option vesting: 25% on the first anniversary of each executive’s start date; remainder monthly over 36 months.
• RSU vesting starts Sept. 15, 2027, then annually over three years in 25% tranches.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609011628PRIMZONEFULLFEED9819741) on September 01, 2026, and is solely responsible for the information contained therein.